Changes related to "Cytarabine (Cytosar)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 21:46, 20 September 2018
   
Page name:

18 September 2018

 m   16:57  B-cell acute lymphoblastic leukemia‎ (diff | hist) . . (+2,320). . Jwarner (talk | contribs) (Daunorubicin, L-Asparaginase, Vincristine, Prednisone {{#subobject:3c9897|Regimen=1}})
 m   16:08  Chronic myelogenous leukemia‎ (diff | hist) . . (+584). . Jwarner (talk | contribs) (Chronic phase, relapsed or refractory)
 m   11:10  Hodgkin lymphoma‎ (diff | hist) . . (+900). . Jwarner (talk | contribs)

17 September 2018

 m   22:40  Acute myeloid leukemia‎‎ (2 changes | history) . . (+1,138). . [Jwarner‎ (2×)]
 m    22:40 (cur | prev) . . (+1,057). . Jwarner (talk | contribs) (Gemtuzumab ozogamicin monotherapy {{#subobject:712055|Regimen=1}})
 m    22:35 (cur | prev) . . (+81). . Jwarner (talk | contribs)
 m   22:14  Diffuse large B-cell lymphoma‎ (diff | hist) . . (+4). . Warner-admin (talk | contribs) (Text replacement - "'''Subset analysis:'''" to "'''Subgroup analysis:'''")
     21:49  Hodgkin lymphoma‎ (diff | hist) . . (+3,047). . Jwarner (talk | contribs)

16 September 2018

 m   21:43  Hodgkin lymphoma‎‎ (2 changes | history) . . (+687). . [Jwarner‎ (2×)]
 m    21:43 (cur | prev) . . (+1,953). . Jwarner (talk | contribs) (CBV, then auto HSCT {{#subobject:935235|Regimen=1}})
 m    21:37 (cur | prev) . . (-1,266). . Jwarner (talk | contribs) (BEAM, then auto HSCT {{#subobject:ed61ad|Regimen=1}})
 m   12:46  Chronic lymphocytic leukemia (CLL/SLL)‎ (diff | hist) . . (+129). . Jwarner (talk | contribs) (Idelalisib monotherapy {{#subobject:b872c5|Regimen=1}})
 m   11:28  CNS lymphoma‎ (diff | hist) . . (+63). . PeterYang (talk | contribs) (CYVE {{#subobject:b2c919|Regimen=1}}: correction of etoposide dose)
 m   09:27  Acute promyelocytic leukemia‎‎ (3 changes | history) . . (-203). . [Jwarner‎ (3×)]
 m    09:27 (cur | prev) . . (-1,344). . Jwarner (talk | contribs) (References)
 m    08:53 (cur | prev) . . (+968). . Jwarner (talk | contribs) (ATRA, Mercaptopurine, Methotrexate {{#subobject:b44ab6|Regimen=1}})
 m    08:07 (cur | prev) . . (+173). . Jwarner (talk | contribs)

15 September 2018

 m   23:04  Acute myeloid leukemia‎ (diff | hist) . . (+743). . Jwarner (talk | contribs) (Clofarabine monotherapy {{#subobject:18ac50|Regimen=1}})
 m   22:47  Hodgkin lymphoma‎‎ (2 changes | history) . . (-407). . [Jwarner‎ (2×)]
 m    22:47 (cur | prev) . . (-423). . Jwarner (talk | contribs) (References)
 m    22:40 (cur | prev) . . (+16). . Jwarner (talk | contribs) (References)

14 September 2018

 m   13:06  Mantle cell lymphoma‎ (diff | hist) . . (+1,472). . Jwarner (talk | contribs) (R-Hyper-CVAD/R-MA {{#subobject:a76238|Regimen=1}})
 m   11:31  Hodgkin lymphoma‎‎ (5 changes | history) . . (+2,435). . [Jwarner‎ (5×)]
 m    11:31 (cur | prev) . . (+29). . Jwarner (talk | contribs) (Investigational agents)
 m    11:22 (cur | prev) . . (+471). . Jwarner (talk | contribs) (Brentuximab vedotin monotherapy {{#subobject:c7e71|Regimen=1}})
 m    11:18 (cur | prev) . . (+1,332). . Jwarner (talk | contribs)
 m    11:08 (cur | prev) . . (+572). . Jwarner (talk | contribs)
 m    11:04 (cur | prev) . . (+31). . Jwarner (talk | contribs)